AQR Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $76M | Buy |
171,031
+27,380
| +19% | +$12.8M | 0.03% | 597 |
|
|
2025
Q4 | $65.1M | Sell |
143,651
-18,032
| -11% | -$7.77M | 0.03% | 592 |
|
|
2025
Q3 | $63.3M | Buy |
161,683
+20,147
| +14% | +$8.42M | 0.04% | 537 |
|
|
2025
Q2 | $62.2M | Sell |
141,536
-4,335
| -3% | -$2M | 0.05% | 480 |
|
|
2025
Q1 | $69.6M | Sell |
145,871
-99,914
| -41% | -$46.6M | 0.07% | 370 |
|
|
2024
Q4 | $99M | Sell |
245,785
-235,076
| -49% | -$109M | 0.13% | 206 |
|
|
2024
Q3 | $223M | Sell |
480,861
-55,253
| -10% | -$26.5M | 0.31% | 58 |
|
|
2024
Q2 | $251M | Sell |
536,114
-130,577
| -20% | -$56.7M | 0.39% | 39 |
|
|
2024
Q1 | $279M | Buy |
666,691
+21,923
| +3% | +$9.27M | 0.47% | 29 |
|
|
2023
Q4 | $262M | Buy |
644,768
+1,271
| +0.2% | +$470K | 0.49% | 30 |
|
|
2023
Q3 | $224M | Buy |
643,497
+31,067
| +5% | +$10.9M | 0.46% | 35 |
|
|
2023
Q2 | $216M | Buy |
612,430
+40,915
| +7% | +$13.8M | 0.46% | 39 |
|
|
2023
Q1 | $180M | Sell |
571,515
-16,079
| -3% | -$4.82M | 0.4% | 49 |
|
|
2022
Q4 | $169M | Buy |
587,594
+93,063
| +19% | +$28.4M | 0.38% | 44 |
|
|
2022
Q3 | $143M | Sell |
494,531
-22,253
| -4% | -$6.4M | 0.35% | 49 |
|
|
2022
Q2 | $144M | Buy |
516,784
+16,840
| +3% | +$4.51M | 0.33% | 57 |
|
|
2022
Q1 | $129M | Sell |
499,944
-98,539
| -16% | -$23.4M | 0.24% | 94 |
|
|
2021
Q4 | $131M | Sell |
598,483
-40,834
| -6% | -$7.94M | 0.24% | 99 |
|
|
2021
Q3 | $116M | Sell |
639,317
-67,436
| -10% | -$13.2M | 0.22% | 112 |
|
|
2021
Q2 | $139M | Sell |
706,753
-203,774
| -22% | -$42.6M | 0.24% | 97 |
|
|
2021
Q1 | $195M | Buy |
910,527
+350,146
| +62% | +$76.9M | 0.32% | 61 |
|
|
2020
Q4 | $129M | Sell |
560,381
-83,887
| -13% | -$19.2M | 0.23% | 104 |
|
|
2020
Q3 | $175M | Buy |
644,268
+32,453
| +5% | +$8.95M | 0.3% | 70 |
|
|
2020
Q2 | $176M | Buy |
611,815
+16,945
| +3% | +$4.59M | 0.28% | 78 |
|
|
2020
Q1 | $138M | Buy |
594,870
+184,560
| +45% | +$42.3M | 0.23% | 107 |
|
|
2019
Q4 | $89.6M | Buy |
410,310
+138,186
| +51% | +$28M | 0.1% | 254 |
|
|
2019
Q3 | $45.8M | Buy |
272,124
+22,158
| +9% | +$3.92M | 0.05% | 399 |
|
|
2019
Q2 | $45M | Sell |
249,966
-194,184
| -44% | -$33.9M | 0.05% | 415 |
|
|
2019
Q1 | $81M | Sell |
444,150
-314,883
| -41% | -$58.2M | 0.09% | 267 |
|
|
2018
Q4 | $126M | Sell |
759,033
-522,311
| -41% | -$90.5M | 0.15% | 171 |
|
|
2018
Q3 | $247M | Buy |
1,281,344
+449,549
| +54% | +$80M | 0.24% | 112 |
|
|
2018
Q2 | $141M | Sell |
831,795
-432,617
| -34% | -$67.1M | 0.14% | 182 |
|
|
2018
Q1 | $206M | Sell |
1,264,412
-253,423
| -17% | -$41.4M | 0.22% | 112 |
|
|
2017
Q4 | $227M | Sell |
1,517,835
-372,855
| -20% | -$55.2M | 0.24% | 114 |
|
|
2017
Q3 | $287M | Buy |
1,890,690
+1,046,806
| +124% | +$158M | 0.34% | 73 |
|
|
2017
Q2 | $109M | Buy |
843,884
+601,942
| +249% | +$72.5M | 0.14% | 189 |
|
|
2017
Q1 | $26.5M | Buy |
241,942
+124,781
| +107% | +$11M | 0.04% | 532 |
|
|
2016
Q4 | $8.63M | Buy |
+117,161
| New | +$9.53M | 0.01% | 813 |
|
|
2016
Q1 | – | Sell |
-46,414
| Closed | -$5.84M | – | 2287 |
|
|
2015
Q4 | $5.84M | Sell |
46,414
-426,800
| -90% | -$51.5M | 0.01% | 872 |
|
|
2015
Q3 | $49.3M | Sell |
473,214
-348,218
| -42% | -$44.7M | 0.1% | 270 |
|
|
2015
Q2 | $101M | Sell |
821,432
-81,323
| -9% | -$10.2M | 0.2% | 140 |
|
|
2015
Q1 | $106M | Buy |
902,755
+275,353
| +44% | +$33M | 0.24% | 118 |
|
|
2014
Q4 | $74.5M | Sell |
627,402
-42,374
| -6% | -$4.77M | 0.16% | 184 |
|
|
2014
Q3 | $75.2M | Buy |
669,776
+185,598
| +38% | +$17.7M | 0.21% | 131 |
|
|
2014
Q2 | $45.8M | Buy |
484,178
+29,200
| +6% | +$2.05M | 0.12% | 218 |
|
|
2014
Q1 | $32.2M | Sell |
454,978
-65,901
| -13% | -$5.22M | 0.1% | 253 |
|
|
2013
Q4 | $38.7M | Buy |
520,879
+80,216
| +18% | +$5.59M | 0.12% | 231 |
|
|
2013
Q3 | $33.4M | Sell |
440,663
-71,882
| -14% | -$5.72M | 0.12% | 226 |
|
|
2013
Q2 | $40.9M | Buy |
+512,545
| New | +$37.7M | 0.15% | 179 |
|
Other funds holding VRTX
VCM
VPM
AQR Capital Management's VRTX Position: Q1 2026 in Review
AQR Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q1 2026, buying an estimated $12.8M and bringing the position to 171,031 shares worth $76M. The position accounts for 0.03% of the portfolio, ranked #597.
AQR Capital Management first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $287M in Q3 2017. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- AQR Capital Management held 171,031 shares of Vertex Pharmaceuticals worth $76M as of Q1 2026.
- AQR Capital Management bought 27,380 Vertex Pharmaceuticals shares in Q1 2026, an estimated $12.8M.
- Vertex Pharmaceuticals made up 0.03% of AQR Capital Management's portfolio in Q1 2026, its #597 holding.
- AQR Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- AQR Capital Management's Vertex Pharmaceuticals position peaked at $287M in Q3 2017.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.